• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Beverage Platform Further Building Shareholder Value – IMG, YCBD, SURG, URG Inside

By: AB Newswire
December 15, 2025 at 13:18 PM EST
NASDAQ: SNYR) Expands FOCUSfactor® Beverage Platform Further Building Shareholder Value – IMG, YCBD, SURG, URG Inside" src="https://www.abnewswire.com/upload/2025/12/1765814934.jpg" alt="Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Beverage Platform Further Building Shareholder Value – IMG, YCBD, SURG, URG Inside" width="225" height="225">

 

Synergy CHC Corp. (NASDAQ: SNYR) continues to build momentum behind its functional beverage strategy, announcing new Direct Store Delivery (DSD) partnerships across Maine and Pennsylvania that expand retail distribution of FOCUSfactor® Focus + Energy RTD beverages and brain-health shots.

The agreements with Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co. represent another step in Synergy’s plan to establish a nationwide DSD footprint, a key driver of velocity and shelf presence in the functional beverage category. Management has emphasized that DSD expansion is essential to scaling beverage revenue efficiently across grocery, convenience, and specialty retail channels.

Along withSynergy CHC Corp. (Nasdaq: SNYR), see SmallCap Stocks to Watch Now: CIMG Inc (Nasdaq: IMG), cbdMD (Nasdaq: YCBD), SurgePays, Inc. (NASDAQ: SURG), Ur-Energy (Nasdaq: URG) and Milestone Pharmaceuticals Inc. (Nasdaq: MIST) all active in intraday trading sessions.

The announcement follows recent investor attention around Roth Capital Partners’ Buy rating and $7 price target, which highlighted the company’s beverage rollout as a central growth catalyst. Roth projected Synergy’s revenue could rise from approximately $35.4 million in 2025 to roughly $55 million in 2026, driven largely by beverage penetration layered onto the company’s existing retail infrastructure. See Complete Roth Capital Report.

Synergy’s beverage strategy benefits from a strong foundation. Its FOCUSfactor® brand carries a 25-year legacy and is already distributed through major national retailers including Costco, Walmart, Amazon, BJ’s, CVS, and Walgreens. The DSD buildout allows Synergy to accelerate last-mile execution, improve in-store placement, and increase repeat purchase behavior—key variables in achieving projected revenue growth.

Roth’s $7 valuation is based on a 6.2x EV/EBITDA multiple applied to projected 2027 results, reflecting expectations that higher beverage mix, strong gross margins, and operating leverage could drive meaningful earnings expansion as sales scale.

With additional DSD partnerships, retail placements, and geographic expansions expected, investors are increasingly focused on whether Synergy’s expanding beverage platform can deliver the $55 million revenue threshold that underpins the current valuation framework heading into 2026.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

More News

View More
News headline image
Paramount Threw a Wrench in Netflix's Bid to Acquire Warner Bros. ↗
Today 10:10 EST
Via MarketBeat
Tickers NFLX PSKY WBD
News headline image
3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most ↗
Today 9:17 EST
Via MarketBeat
Tickers AMGN JNJ LLY SYK
News headline image
Unassuming Evergy Energy: The AI Boost Your Income Portfolio Needs ↗
Today 8:20 EST
Via MarketBeat
Topics Artificial Intelligence
Tickers EVRG GOOGL META NVDA
News headline image
Pfizer Adds to Its Big Bet on Weight Loss Drugs ↗
Today 7:03 EST
Via MarketBeat
Tickers JNJ LLY NVO PFE REGN
News headline image
ServiceNow’s $7 Billion Gamble: Panic or Opportunity? ↗
December 15, 2025
Via MarketBeat
Tickers NOW

Recent Quotes

View More
Symbol Price Change (%)
AMZN  223.18
+0.64 (0.29%)
AAPL  273.31
-0.80 (-0.29%)
AMD  206.69
-0.90 (-0.43%)
BAC  55.12
-0.20 (-0.37%)
GOOG  308.72
-0.60 (-0.19%)
META  651.62
+4.12 (0.64%)
MSFT  473.80
-1.02 (-0.21%)
NVDA  176.12
-0.17 (-0.10%)
ORCL  187.86
+2.94 (1.59%)
TSLA  474.62
-0.69 (-0.14%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap